• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group

    10/11/22 9:00:00 AM ET
    $CERN
    $HQY
    $MDRX
    Managed Health Care
    Health Care
    Real Estate
    Real Estate
    Get the next $CERN alert in real time by email

    Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy

    Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market.

    "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longstanding focus in healthcare and technology. As we continue finding investment opportunities at the intersection of these industries, Paul's significant experience creating and executing a strategic vision for businesses in Healthcare IT will be greatly beneficial as we add more high-quality companies seeking to improve the healthcare ecosystem to our portfolio."

    In this role, Black will support the healthcare group in deal sourcing, due diligence for potential investments, and developing new relationships with founders and management teams across the healthcare landscape. He will also serve as an advisor to portfolio companies to support their growth.

    "THL's thesis-driven approach and dedicated focus on Healthcare IT has enabled it to work with unique companies across the healthcare landscape," said Paul Black. "I am pleased to join such an exceptional team and look forward to advancing the firm's strategy."

    Prior to joining THL, Black served 10 years as a Director and CEO of Allscripts, (NASDAQ:MDRX) a global leader in healthcare information technology solutions. Before that, he was the COO of Cerner Corporation (NASDAQ:CERN) for more than a decade. Black is currently a director of HealthEquity (NASDAQ:HQY), Community CareLink, The Advancement Board University of Kansas Health System and The Harry S. Truman Presidential Library & Museum.

    About Thomas H. Lee Partners, L.P.

    Thomas H. Lee Partners, L.P. ("THL") is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions. THL couples deep sector expertise through an Identified Sector Opportunity ("ISO") process with dedicated internal operating resources from its Strategic Resource Group ("SRG") to transform and build great companies of lasting value in partnership with management. The Firm's domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. THL has been an active investor in Healthcare and Healthcare IT for decades with investments in Intelligent Medical Objects, Nextech, Qventus, Intermedix, SeniorLink and numerous other Healthcare and Technology companies. Since 1974, THL has raised more than $34 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221011005107/en/

    Get the next $CERN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CERN
    $HQY
    $MDRX

    CompanyDatePrice TargetRatingAnalyst
    HealthEquity Inc.
    $HQY
    5/22/2025$105.00 → $112.00Outperform
    RBC Capital Mkts
    HealthEquity Inc.
    $HQY
    3/25/2025$120.00 → $115.00Outperform → Strong Buy
    Raymond James
    HealthEquity Inc.
    $HQY
    12/4/2024$126.00Outperform
    Mizuho
    HealthEquity Inc.
    $HQY
    11/15/2024$108.00Neutral
    Goldman
    HealthEquity Inc.
    $HQY
    4/4/2024$101.00Mkt Outperform
    JMP Securities
    HealthEquity Inc.
    $HQY
    4/2/2024$86.00 → $108.00Overweight
    JP Morgan
    Veradigm Inc.
    $MDRX
    3/19/2024$15.00 → $10.00Buy → Hold
    Deutsche Bank
    Veradigm Inc.
    $MDRX
    1/3/2024$11.00Equal Weight
    Barclays
    More analyst ratings

    $CERN
    $HQY
    $MDRX
    SEC Filings

    View All

    SEC Form 144 filed by HealthEquity Inc.

    144 - HEALTHEQUITY, INC. (0001428336) (Subject)

    9/5/25 4:08:20 PM ET
    $HQY
    Real Estate

    SEC Form 10-Q filed by HealthEquity Inc.

    10-Q - HEALTHEQUITY, INC. (0001428336) (Filer)

    9/2/25 4:03:47 PM ET
    $HQY
    Real Estate

    HealthEquity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HEALTHEQUITY, INC. (0001428336) (Filer)

    9/2/25 4:02:17 PM ET
    $HQY
    Real Estate

    $CERN
    $HQY
    $MDRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results

    Highlights of the second quarter include: Revenue of $325.8 million, an increase of 9% compared to $299.9 million in Q2 FY25.Net income of $59.9 million, an increase of 67% compared to $35.8 million in Q2 FY25, with non-GAAP net income of $94.6 million, an increase of 24% compared to $76.3 million in Q2 FY25.Net income per diluted share of $0.68, an increase of 70% compared to $0.40 in Q2 FY25, with non-GAAP net income per diluted share of $1.08, an increase of 26% compared to $0.86 in Q2 FY25.Adjusted EBITDA of $151.1 million, an increase of 18% compared to $128.3 million in Q2 FY25.10.0 million HSAs, an increase of 6% compared to Q2 FY25.Total HSA Assets of $33.1 billion, an increase of

    9/2/25 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity's AI-Powered Tool Recognized for Innovation in Streamlining Benefits Education

    DRAPER, Utah, Aug. 29, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced that its innovative AI-powered educational tool, HSAnswers, has received multiple prestigious industry awards recognizing its excellence in artificial intelligence and benefits education innovation. HSAnswers is designed to provide fast and reliable responses to HSAs questions and other consumer-directed benefits (CDBs). The tool uses generative artificial intelligence to deliver personalized conversation and insights powered by HealthEquity's comprehensive knowledge base and industry expertise.

    8/29/25 11:00:00 AM ET
    $HQY
    Real Estate

    Veradigm Amends and Extends Stockholder Rights Plan

    Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the "Rights Plan"). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to February 20, 2026. In addition, the amendment to the Rights Plan changes the triggering threshold such that the rights would become exercisable only if a person or group acquires bene

    8/20/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    $CERN
    $HQY
    $MDRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4) (Amendment)

    4/A - Veradigm Inc. (0001124804) (Issuer)

    3/15/24 5:16:45 PM ET
    $MDRX
    EDP Services
    Technology

    Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    3/4/24 9:50:46 PM ET
    $MDRX
    EDP Services
    Technology

    $CERN
    $HQY
    $MDRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts resumed coverage on HealthEquity with a new price target

    RBC Capital Mkts resumed coverage of HealthEquity with a rating of Outperform and set a new price target of $112.00 from $105.00 previously

    5/22/25 9:53:52 AM ET
    $HQY
    Real Estate

    HealthEquity upgraded by Raymond James with a new price target

    Raymond James upgraded HealthEquity from Outperform to Strong Buy and set a new price target of $115.00 from $120.00 previously

    3/25/25 8:22:31 AM ET
    $HQY
    Real Estate

    Mizuho initiated coverage on HealthEquity with a new price target

    Mizuho initiated coverage of HealthEquity with a rating of Outperform and set a new price target of $126.00

    12/4/24 7:41:08 AM ET
    $HQY
    Real Estate

    $CERN
    $HQY
    $MDRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dilsaver Evelyn S exercised 15,000 shares at a strike of $21.27 and sold $322,916 worth of shares (3,461 units at $93.30), increasing direct ownership by 31% to 48,208 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    9/9/25 3:37:23 PM ET
    $HQY
    Real Estate

    FOUNDER AND VICE CHAIRMAN Neeleman Stephen gifted 3,000 shares (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    7/31/25 4:23:15 PM ET
    $HQY
    Real Estate

    New insider Gathright Michael claimed ownership of 27,006 shares (SEC Form 3)

    3 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    7/14/25 2:27:15 PM ET
    $HQY
    Real Estate

    $CERN
    $HQY
    $MDRX
    Financials

    Live finance-specific insights

    View All

    HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results

    Highlights of the second quarter include: Revenue of $325.8 million, an increase of 9% compared to $299.9 million in Q2 FY25.Net income of $59.9 million, an increase of 67% compared to $35.8 million in Q2 FY25, with non-GAAP net income of $94.6 million, an increase of 24% compared to $76.3 million in Q2 FY25.Net income per diluted share of $0.68, an increase of 70% compared to $0.40 in Q2 FY25, with non-GAAP net income per diluted share of $1.08, an increase of 26% compared to $0.86 in Q2 FY25.Adjusted EBITDA of $151.1 million, an increase of 18% compared to $128.3 million in Q2 FY25.10.0 million HSAs, an increase of 6% compared to Q2 FY25.Total HSA Assets of $33.1 billion, an increase of

    9/2/25 4:01:00 PM ET
    $HQY
    Real Estate

    Veradigm Amends and Extends Stockholder Rights Plan

    Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the "Rights Plan"). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to February 20, 2026. In addition, the amendment to the Rights Plan changes the triggering threshold such that the rights would become exercisable only if a person or group acquires bene

    8/20/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    HealthEquity Announces Dates to Report Second Quarter Earnings and Presentations at Investor Conferences

    DRAPER, Utah, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced plans to release its second quarter of fiscal 2026 financial results following the close of regular stock market trading hours on Tuesday, September 2, 2025. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, September 2, 2025, at 4:30 p.m. Eastern Time during which management will review the Company's financial results. HealthEquity Second Quarter Fiscal Year 2026 Results Conference CallDate: September 2, 2025Time: 4:30 p.m. Eastern Time /

    8/6/25 9:00:00 AM ET
    $HQY
    Real Estate

    $CERN
    $HQY
    $MDRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Veradigm Inc.

    SC 13G - Veradigm Inc. (0001124804) (Subject)

    11/14/24 4:05:58 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

    SC 13G/A - Veradigm Inc. (0001124804) (Subject)

    11/14/24 1:11:13 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

    SC 13G/A - Veradigm Inc. (0001124804) (Subject)

    11/8/24 10:29:29 AM ET
    $MDRX
    EDP Services
    Technology

    $CERN
    $HQY
    $MDRX
    Leadership Updates

    Live Leadership Updates

    View All

    Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership

    Appoints Jonathan Sacks and Bruce Felt to the Board Lou Silverman to Succeed Greg Garrison as Chairman Veradigm Inc. (OTC:MDRX) ("Veradigm" or the "Company"), a leading provider of healthcare data and technology solutions, announced today its Board of Directors (the "Board") appointed two new independent directors, Jonathan Sacks and Bruce Felt, to the Board, effective March 19, 2025, and that Lou Silverman will succeed Greg Garrison as Chairman upon his retirement from the Board on that date. In addition, Mr. Felt will become the Chair of the Audit Committee of the Board upon Mr. Garrison's retirement. Further, independent director Vinit Asar has been named Chair of the Nominating and Go

    3/18/25 4:47:00 PM ET
    $CMBM
    $DOMO
    $EVH
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Computer Software: Prepackaged Software
    Other Consumer Services

    Veradigm Announces Board Expansion and Changes

    Appoints Vinit Asar and Louis Silverman to its Board of Directors Agrees to Add Two Additional Directors Veradigm® (OTC:MDRX) ("Veradigm" or the "Company"), a leading provider of healthcare data and technology solutions, announced today it has entered into a Cooperation Agreement (the "Agreement") with Kent Lake PR LLC ("Kent Lake"). The Agreement aligns with the Board's request for input from shareholders regarding board composition on January 30, 2025, and a desire to conduct an orderly refreshment of the Board following the conclusion of the exploration of strategic alternatives. As part of the Agreement, the Board has appointed two new independent directors, Vinit Asar and Louis Silve

    2/20/25 4:02:00 PM ET
    $MDRX
    $OCX
    $ZIMV
    EDP Services
    Technology
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    HealthEquity Reports Year-End Sales Metrics

    DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced its HSAs, HSA Assets and Total Accounts as of its fiscal year ended January 31, 2025. The Company also affirmed its guidance for fiscal 2025 and 2026, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations. The total number of HSAs as of January 31, 2025 was 9.9 million, an increase of 14%, from 8.7 million as of January 31, 2024. The Company closed its fiscal year 2025 with 17.0 million Total Accounts, an increase of 9%, from 15.7 million as of January 31,

    2/18/25 4:01:00 PM ET
    $HQY
    Real Estate